Novavax
General Information
Identification Code: 334922247628-17
Website: www.novavax.com
Entity Form: Delaware Corporation
Registration Category: Companies & groups
Registration Date: 9/14/2022
Last Update: 6/27/2024
EP Accredited Number: 3
Mission & Interests
Goals: Novavax, Inc. (Nasdaq: NVAX) is a biotechnology company that promotes improved health globally through the discovery, development, and commercialization of innovative vaccines to prevent serious infectious diseases. Our proprietary recombinant technology platform harnesses the power and speed of genetic engineering to efficiently produce highly immunogenic nanoparticles designed to address urgent global health needs. To learn more, please visit www.novavax.com
Interests Represented: Promotes their own interests or the collective interests of their members
Interests:
- Business and industry
- Digital economy and society
- Public health
- Research and innovation
- Trade
Levels of Interest:
- global
- national
- sub-national
- european
Activities
Main EU Legislative Proposals: Novavax regularly interacts with the EU institutions and engages on issues relevant to the company, including the fight against COVID-19, pandemic preparedness, vaccination and the promotion of policies supporting global health. Key policies and initiatives include: EU vaccines strategy and policy, the review of the general pharmaceutical legislation, and the work of the European Health Emergency Preparedness and Response Authority.
Communication Activities: We regularly respond to relevant EU consultations.
Inter-institutional or Unofficial Groupings: N/A
Head Office
Address: 21 Firstfield Road
Post Code: 20878
City: Gaithersburg
Country: UNITED STATES
Phone:
Indic Phone: 1
Phone Number: 2402682000
EU Office
Address: Square de Meeûs, 37
Post Code: 1000
City: Brussels
Country: BELGIUM
Phone:
Indic Phone: 32
Phone Number: 478975446
Financial Data
Closed Year:
Start Date:
End Date:
Funding Sources:
Contributions:
Total Budget: 0
Grants:
Current Year:
Grants:
Membership Information
Members25 Percent: 1
Members: 2
Members F T E: 1.25
Structure
Structure Type: Structure
Is Member Of: none
Organisation Members: Vaccines Europe and the International Federation of Pharmaceutical Manufacturers and Associations
Current Job Opportunities
mid-levelBrussels, Francefull-time
Posted: 8/21/2025